Pharma Tech

Charles River and MVC to develop enterovirus vaccine

Aug 21, 2026, 8:27 AM

Read Full Article → Charles River and MVC to develop enterovirus vaccine

Translate article text

Choose a language and wait for the translated text.

Charles River Laboratories International and MVC have entered a collaboration to support the characterisation, along with validation of the virus seed bank for the latter’s next-generation multivalent enterovirus vaccine.